دورية أكاديمية

Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial

التفاصيل البيبلوغرافية
العنوان: Pharmacokinetics, Efficacy, and Safety of a SARS-CoV-2 Antibody Treatment in Pediatric Participants: An Open-Label Addendum of a Placebo-Controlled, Randomized Phase 2/3 Trial
المؤلفون: Upadhyaya, Himanshu P.Aff1, IDs4012102300832y_cor1, Chien, Jenny Y., Long, Amanda J., Bohm, Martin S., Kallewaard, Nicole L., Macpherson, Lisa F., Patel, Dipak R., Hufford, Matthew M., Krull, Constance J., Ang, Jocelyn Y.Aff2, Aff7, Chen, Peter, Muller, William J., Potts, Jeffrey A., Quinn, Timothy, Williams, Mark
المصدر: Infectious Diseases and Therapy. 12(7):1861-1873
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:21938229
21936382
DOI:10.1007/s40121-023-00832-y